- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.11. | Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans | 1 | Seeking Alpha | ||
| 19.11. | Vivos Therapeutics GAAP EPS of -$0.49, revenue of $6.8M | 4 | Seeking Alpha | ||
| 19.11. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 | 298 | GlobeNewswire (Europe) | Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference... ► Artikel lesen | |
| 19.11. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.11. | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11. | Vivos Therapeutics, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 04.11. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 24.10. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09. | Vivos Therapeutics, Inc: Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device | 200 | GlobeNewswire (Europe) | LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development... ► Artikel lesen | |
| 17.09. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment | 175 | GlobeNewswire (Europe) | LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development... ► Artikel lesen | |
| 12.09. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.08. | Vivos Therapeutics GAAP EPS of -$0.55, revenue of $3.82M | 3 | Seeking Alpha | ||
| 19.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update | 237 | GlobeNewswire (Europe) | Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos' differentiated array of highly effective OSA treatments... ► Artikel lesen | |
| 19.08. | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 30.07. | Vivos Therapeutics appoints two executives to support growth strategy | 3 | Investing.com | ||
| 30.07. | Vivos Therapeutics, Inc: Vivos Therapeutics Adds to Management Team to Support Expansion and Growth | 1 | GlobeNewswire (USA) | ||
| 01.07. | Vivos Therapeutics stock soars after Medicare approves VidaSleep oral appliance | 1 | Investing.com | ||
| 01.07. | Vivos Therapeutics, Inc: Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance | 1 | GlobeNewswire (USA) | ||
| 26.06. | Vivos Therapeutics Stock Climbs 9% On Positive Pediatric Sleep Apnea Study | - | RTTNews |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,420 | -0,96 % | Eckert & Ziegler liefert Actinium-225 an SK Biopharmaceuticals | Eckert & Ziegler hat einen Liefervertrag mit dem südkoreanischen Biotechnologieunternehmen SK Biopharmaceuticals geschlossen. Im Rahmen der Vereinbarung wird Eckert & Ziegler das Alpha-emittierende... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,086 | 0,00 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,655 | +9,75 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights Three REYOBIQ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting | ||
| NUGEN MEDICAL DEVICES | 0,023 | -5,65 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| CARDINAL HEALTH | 170,25 | -0,55 % | Cardinal Health completes acquisition of Solaris Health | Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,659 | +3,78 % | Atossa Therapeutics Inc: Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum | Company positioned to pursue expedited regulatory pathways in metastatic, neoadjuvant, and risk-reduction settings
SEATTLE, Dec. 4, 2025 /PRNewswire/ -- Atossa... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,119 | +6,24 % | UniDoc erhält Bestellung für Health Cubes | - Die drei Einheiten sind für Demonstrationszwecke bei Verizon Innovation Labs
bestimmt
VANCOUVER, BC / 25. November 2025 / IRW-Press / UniDoc Health Corp. (CSE: UDOC) (FWB: L7T)... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,690 | +0,76 % | EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.11.2025 / 17:23... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,010 | -0,82 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 48,010 | +1,69 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 35,430 | +6,78 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,400 | +1,57 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,150 | -1,63 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen |
Das Unternehmen VIVOS THERAPEUTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +3,86 % bei einem Aktienkurs von 2,150 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.